At stage 3, STARD13, CBFA2T3, RECK, and SASH1 had strong accordant/discordant effects on expression of genes in cancer, while APC, EXT1, NBL, KLK10, and PTCH1 had very weak accordant/discordant impacts on expression of genes in cancer. The gene discussed is RECK; the disease is cancer.